Hyoscine Butylbromide for Chronic Use

Introduction to Hyoscine Butylbromide

The American Gastroenterological Association recommends hyoscine butylbromide over dicyclomine for chronic use due to superior tolerability and fewer central nervous system effects 1

Hyoscine butylbromide is a quaternary ammonium compound with significantly less lipid solubility than dicyclomine, which reduces blood-brain barrier penetration and minimizes central nervous system side effects 1

The intramuscular route is particularly effective for hyoscine butylbromide because the oral formulation is poorly absorbed, making IM administration more suitable for both acute relief and chronic home use 1, 2

Side effects of hyoscine butylbromide are primarily anticholinergic (dry mouth, visual disturbance, dizziness) but are generally fewer and less severe than with dicyclomine 3, 1
Both medications share anticholinergic mechanisms, so monitor for additive anticholinergic effects if using concurrently, particularly dry mouth, constipation, and urinary retention 3, 4
Anticholinergics including both dicyclomine and hyoscine butylbromide are contraindicated in patients with recent bowel anastomosis 1

The British Society of Gastroenterology guidelines recognize antispasmodics as effective first-line treatments for IBS pain, with anticholinergic agents like dicyclomine showing slightly better efficacy than direct smooth muscle relaxants 3, 4